Products | February 10, 2009

Quasar Respiratory Motion Inserts

Quasar Respiratory Motion Inserts

Related Content

A recent analysis from Mordor Intelligence offers valuable observations into a market segment which finds itself needing to answer a growing global need for radiation therapy.
News | Radiation Oncology
Radiotherapy Market Forecast Analyzes Significant Growth

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
ARCH-AI Can Help Radiology Sites Safely and Effectively Implement AI in Daily Practice
News | Artificial Intelligence
American College of Radiology Launches First Medical Practice Artificial Intelligence Quality Assurance Program

June 27, 2024 — The American College of Radiology (ACR) launched the ACR Recognized Center for Healthcare-AI (ARCH-AI) ...

Time June 27, 2024
arrow
Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry Services brand, at the 2023 Radiological Society of North America (RSNA) Meeting
News | Quality Assurance (QA)
Mirion Medical Introduces Instadose VUE Dosimeter at Radiological Society of North America (RSNA) Annual Meeting

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
RTsafe’s PseudoPatient that is used to verify radiotherapy dosage and accuracy ahead of patient treatment.
News | Quality Assurance (QA)
RTsafe Announces First Use of its PseudoPatient Patient-specific Quality Assurance Process by Fundación Instituto Valenciano de Oncología (IVO)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
arrow
Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion’s CEO, Tom Logan, who had been acting as President of the business segment.
News | Quality Assurance (QA)
Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

October 7, 2022 — Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and ...

Time October 07, 2022
arrow
By combining the portfolios of both companies, IBA Dosimetry and ScandiDos can accomplish this vision, offering an increasingly extensive suite of products that provide a consistent solution for all aspects of radiotherapy quality assurance.
News | Radiation Therapy
IBA and ScandiDos Form Strategic Alliance to Increase Access to Safe Radiotherapy

September 1, 2022 — IBA S.A., a leader in particle accelerator technology and a leader in dosimetry quality assurance ...

Time September 01, 2022
arrow
IBA (Ion Beam Applications S.A.), a leader in particle accelerator technology and the leader in dosimetry quality assurance solutions, today announces it has acquired Modus Medical Devices Inc. (Modus QA), a Canadian company based in London, Ontario, specialized in phantoms for quality assurance for radiation therapy.
News | Radiology Business
IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc.

May 3, 2022 — IBA (Ion Beam Applications S.A.), a leader in particle accelerator technology and the leader in dosimetry ...

Time May 03, 2022
arrow
Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., today announced the release of the SunSCAN 3D cylindrical water scanning system for linear accelerator (linac) commissioning, beam scanning and annual Quality Assurance (QA) in Radiation Therapy.
News | Quality Assurance (QA)
Sun Nuclear Introduces SunSCAN 3D, Next-Generation Cylindrical Water Scanning System

May 3, 2022 — Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., today announced the ...

Time May 03, 2022
arrow
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the close of an $80 million equity financing.
News | Intensity Modulated Radiation Therapy (IMRT)
RefleXion Raises $80 Million to Broaden Cancer Treatment Options

March 14, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time March 14, 2022
arrow
Sponsored Content | Videos | Quality Assurance (QA)
Talking Trends with Sun Nuclear: Supporting CT Protocol Optimization

Sun Nuclear highlighted two resources for CT Quality Assurance at RSNA 2021. ITN visited their booth to learn more about ...

Time January 31, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now